Publication | Closed Access

Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti–IL-5 receptor α antibody, in a phase I study of subjects with mild asthma

AsthmaBiologic ActivityMild AsthmaClinical AllergyMedicineImmunologyPharmacotherapyAllergic RhinitisImmunotherapyPharmacologySafety Profile